We value your privacy

We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies.

Customise Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.

No cookies to display.

Tag: #MaxImmun

MaxImmun was at Florence !

📍MaxImmun was at Florence in Italy for IUMS 2024, the 18th Congress of the International Union of Microbiological Societies, October 23-25, 2024.

October 2024 : Brunswick !

🔬Mark Broenstrup and Vivek K. Mishra (Ph.D.) from Helmholtz-Zentrum für Infektionsforschung working on the optimization of an AMP-inducer molecule by medicinal chemistry.Brunswick, Germany, October, 2024. 🧪 MaxImmun, Mark Broenstrup, Vivek K. Mishra (Ph.D.), Dan Andersson, Nathalie Vergnolle, Al-Mourabit Ali, Sylvain PETEK, Laurent de Crasto, Brice Sperandio, PhD

Welcome to Toulouse !

🔬Weronika Wozniak from École normale supérieure and David Sagnat from IRSD Institut de Recherche en Santé Digestive studying the impact of AMP-inducer molecules on the physiology of human organoïds. Toulouse, France, September 9-13, 2024. 🧫 MaxImmun, Nathalie Vergnolle, Mark Broenstrup, Dan Andersson, Al-Mourabit Ali, Sylvain PETEK, Laurent de Crasto, Brice Sperandio, PhD

Our European partners !

Thank you to all the European partners of the MaxImmun consortium for their participation to the kick-off meeting at Institut de France in Paris, France, June 14, 2024. 🇪🇺 🇫🇷 🇸🇪 🇩🇪 Mark Broenstrup, Dan Andersson, Nathalie Vergnolle, David Sagnat, Laurent de Crasto, Al-Mourabit Ali, Sylvain PETEK, Weronika Wozniak, William Bourumeau, Brice Sperandio, PhD

MaxImmun was at Bordeaux !

MaxImmun was at Bordeaux in France for #3DModelsInBiology, a symposium on cellular models developed for biology and medicine, June 20, 2024. David Sagnat, Nathalie Vergnolle

MaxImmun was at Marseille !

MaxImmun was at Marseille in France for #AMP2024, the 8th International Symposium on Antimicrobial Peptides, June 5-7, 2024. Weronika Wozniak, William Bourumeau

MaxImmun is a Horizon Europe project supported by the European Union, through the European Innovation Council
Grant agreement N°101129622
Start date : January 1, 2024
Duration : 48 months

Our newsletter